Clorox (NYS: CLX) is expected to report Q4 earnings around Aug. 3. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Clorox's revenues will grow 3.4% and EPS will improve 0.8%.
The average estimate for revenue is $1.53 billion. On the bottom line, the average EPS estimate is $1.27.
Last quarter, Clorox logged revenue of $1.40 billion. GAAP reported sales were 7.4% higher than the prior-year quarter's $1.30 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.02. GAAP EPS of $1.00 for Q3 were 8.3% lower than the prior-year quarter's $1.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.3%, 180 basis points worse than the prior-year quarter. Operating margin was 16.1%, 220 basis points worse than the prior-year quarter. Net margin was 9.4%, 220 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $5.46 billion. The average EPS estimate is $4.07.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 827 members out of 866 rating the stock outperform, and 39 members rating it underperform. Among 278 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 271 give Clorox a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $69.64.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Clorox. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Clorox to My Watchlist.
The article Will These Numbers From Clorox Be Good Enough for You? originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool owns shares of The Clorox Company. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.